Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target.
Saved in:
| Title: | Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target. |
|---|---|
| Authors: | Perez M; Department of Translational Medicine, Translational Glycobiology Institute at FIU, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA., Chakraborty A; Department of Translational Medicine, Translational Glycobiology Institute at FIU, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA., Lau LS; Department of Translational Medicine, Translational Glycobiology Institute at FIU, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA., Mohammed NBB; Department of Translational Medicine, Translational Glycobiology Institute at FIU, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA., Dimitroff CJ; Department of Translational Medicine, Translational Glycobiology Institute at FIU, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA. |
| Source: | The British journal of dermatology [Br J Dermatol] 2021 Aug; Vol. 185 (2), pp. 294-301. Date of Electronic Publication: 2021 May 04. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Review |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
